These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38777171)

  • 21. Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020.
    Kalligeros M; Vassilopoulos A; Vassilopoulos S; Victor DW; Mylonakis E; Noureddin M
    Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1330-1332.e4. PubMed ID: 37949334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term risk of cardiovascular disease associated with MASLD and different cardiometabolic risk factors in IBD patients: A prospective cohort study.
    Zhang Q; Xu F; Liu S; Zhu S; Zhang S; Wu J; Wu S
    Liver Int; 2024 Sep; 44(9):2315-2328. PubMed ID: 38819640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings.
    Lee CM; Yoon EL; Kim M; Kang BK; Cho S; Nah EH; Jun DW
    Hepatology; 2024 Jun; 79(6):1393-1400. PubMed ID: 38100294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
    Canivet CM; Boursier J; Loomba R
    Semin Liver Dis; 2024 Feb; 44(1):35-42. PubMed ID: 38531378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD.
    Chen L; Tao X; Zeng M; Mi Y; Xu L
    J Hepatol; 2024 Feb; 80(2):e64-e66. PubMed ID: 37714381
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
    Chen YT; Chen TI; Yang TH; Yin SC; Lu SN; Liu XR; Gao YZ; Lin CJ; Huang CW; Huang JF; Yeh ML; Huang CF; Dai CY; Chuang WL; Yang HI; Yu ML; Lee MH
    Am J Gastroenterol; 2024 Apr; ():. PubMed ID: 38534155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis.
    Mori K; Akiyama Y; Tanaka M; Sato T; Endo K; Hosaka I; Hanawa N; Sakamoto N; Furuhashi M
    J Gastroenterol Hepatol; 2024 Jul; 39(7):1382-1393. PubMed ID: 38629681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Steatotic Liver Disease Based on a New Nomenclature in the Japanese Population: A Health Checkup-Based Cross-Sectional Study.
    Miwa T; Tajirika S; Imamura N; Adachi M; Horita R; Hanai T; Fukao T; Shimizu M; Yamamoto M
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.
    Chen L; Tao X; Zeng M; Li Y; Han J; Wang Y; Liu Y; Shi R; Su R; Xu L; Mi Y
    J Med Virol; 2024 Apr; 96(4):e29613. PubMed ID: 38634477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between shadow economy and pollution: empirical analysis based on panel data of northeast China.
    Pang J; Mu H; Zhang M
    Environ Sci Pollut Res Int; 2020 Jun; 27(17):21353-21363. PubMed ID: 32274690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: Has MetALD met the presumption? Authors' reply.
    Tamaki N; Kimura T; Wakabayashi SI; Umemura T; Izumi N; Loomba R; Kurosaki M
    Aliment Pharmacol Ther; 2024 Jul; 60(1):99-100. PubMed ID: 38757828
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: Has MetALD met the presumption?
    Tan CK
    Aliment Pharmacol Ther; 2024 Jul; 60(1):97-98. PubMed ID: 38757852
    [No Abstract]   [Full Text] [Related]  

  • 33. MetALD accounts for a large part of what we call MASLD!
    Rudler M; Bouzbib C; Thabut D
    J Hepatol; 2024 Jun; ():. PubMed ID: 38925268
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.
    Lee HH; Lee HA; Kim EJ; Kim HY; Kim HC; Ahn SH; Lee H; Kim SU
    Gut; 2024 Feb; 73(3):533-540. PubMed ID: 37907259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Applications of Landing Strategies in Badminton Footwork Training on a Backhand Side Lateral Jump Smash.
    Hung MH; Chang CY; Lin KC; Hung CL; Ho CS
    J Hum Kinet; 2020 Jul; 73():19-31. PubMed ID: 32774534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction.
    Park HJ; Lee S; Lee JS
    Abdom Radiol (NY); 2024 Sep; 49(9):3036-3044. PubMed ID: 38587630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the landscape of steatotic liver disease in the general US population.
    Ciardullo S; Carbone M; Invernizzi P; Perseghin G
    Liver Int; 2023 Nov; 43(11):2425-2433. PubMed ID: 37592856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Not Available].
    Hansen CD; Lindvig KP; Grønbæk H; Gluud LL; Thiele M; Krag A
    Ugeskr Laeger; 2024 May; 186(19):. PubMed ID: 38808766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Insults of a MASH Diet and Alcohol Binges Activate Intercellular Communication and Neutrophil Recruitment via the NLRP3-IL-1β Axis in the Liver.
    Babuta M; Nagesh PT; Datta AA; Remotti V; Zhuang Y; Mehta J; Lami F; Wang Y; Szabo G
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression.
    Osna NA; Tikhanovich I; Ortega-Ribera M; Mueller S; Zheng C; Mueller J; Li S; Sakane S; Weber RCG; Kim HY; Lee W; Ganguly S; Kimura Y; Liu X; Dhar D; Diggle K; Brenner DA; Kisseleva T; Attal N; McKillop IH; Chokshi S; Mahato R; Rasineni K; Szabo G; Kharbanda KK
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.